Why Neuronetics Blasted 39% Higher Today
Neuronetics (NASDAQ: STIM), a company that focuses on what it describes as "products that improve the quality of life for patients who suffer from psychiatric disorders," shot 39% higher on Tuesday. Neuronetics earned $12.3 million in revenue for the quarter, 7% higher on a year-over-year basis. Neuronetics specializes in transcranial magnetic stimulation (TMS) in which magnetic fields are used to stimulate nerve cells located in a part of the brain associated with mood in order to help alleviate clinical depression.
